33.0¢ HEALTHCARE SHOWCASE Put your Investment Case to Hotcopper's 700K monthly unique visitors. OCC closed down 1.43 percent on Thursday, August 6, 2020, on 66 percent of normal volume. Join the HotCopper ASX share market forum today for free. HotCopper has news, discussion, prices and market data on ORTHOCELL LIMITED. Australia's largest stock trading and investment forum 33.0¢ Are you a Company Director ? DISCOVER THE REGENEUS STORY A clinical-stage regenerative medicine company using stem cell technologies to develop a portfolio of novel cell-based therapies to address unmet medical needs in human health markets with a focus on neuropathic pain, including osteoarthritis and various... A clinical-stage regenerative medicine company using stem cell technologies to develop a portfolio of novel cell-based therapies to address unmet medical needs in human health markets with a focus on neuropathic pain, including osteoarthritis and various... Australia's largest stock trading and investment forum Target our investor community with our suite of Hotcopper Advertising opportunities. 33.0¢ 34.0¢ The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Shares rose an unbelievable 377 per cent yesterday, to 52c, after the company revealed that its CelGro technology was helping patients who’d suffered severe nerve damage regain sensation and function. Very easy to panic amidst the aggressive risk-off sentiment in small caps'. HEALTHCARE SHOWCASE Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and related technologies for the repair and regeneration of human tendon, bone, nerve, and cartilage defects i ... Show more .
DISCOVER THE REGENEUS STORY
Australia's largest stock trading and investment forum DISCOVER THE REGENEUS STORY Australia's largest stock trading and investment forum OCC …
... (ASX:OCC). 33.0¢ A clinical-stage regenerative medicine company using stem cell technologies to develop a portfolio of novel cell-based therapies to address unmet medical needs in human health markets with a focus on neuropathic pain, including osteoarthritis and various... A clinical-stage regenerative medicine company using stem cell technologies to develop a portfolio of novel cell-based therapies to address unmet medical needs in human health markets with a focus on neuropathic pain, including osteoarthritis and various... Orthocell Limited (OCC) is engaged in the development and commercialization of novel collagen medical devices and cellular therapies for the repair and regeneration of human tendons, bone, nerve and cartilage defects. Claim your IR profile Find the latest ORTHOCELL FPO (OCC.AX) stock quote, history, news and other vital information to help you with your stock trading and investing. The ASX Group's activities span primary and secondary market services, including capital formation and hedging, trading and price discovery (Australian Securities Exchange) central counter party risk transfer (ASX Clearing Corporation); and securities settlement for both the equities and fixed income markets (ASX Settlement Corporation). Target our investor community with our suite of Hotcopper Advertising opportunities. 34.0¢ It has a Good Manufacturing Process (GMP) facility in place for quality control and also holds an ISO certification for the manufacture of its products such as CelGro.
DISCOVER THE REGENEUS STORY
Australia's largest stock trading and investment forum DISCOVER THE REGENEUS STORY Australia's largest stock trading and investment forum OCC …
... (ASX:OCC). 33.0¢ A clinical-stage regenerative medicine company using stem cell technologies to develop a portfolio of novel cell-based therapies to address unmet medical needs in human health markets with a focus on neuropathic pain, including osteoarthritis and various... A clinical-stage regenerative medicine company using stem cell technologies to develop a portfolio of novel cell-based therapies to address unmet medical needs in human health markets with a focus on neuropathic pain, including osteoarthritis and various... Orthocell Limited (OCC) is engaged in the development and commercialization of novel collagen medical devices and cellular therapies for the repair and regeneration of human tendons, bone, nerve and cartilage defects. Claim your IR profile Find the latest ORTHOCELL FPO (OCC.AX) stock quote, history, news and other vital information to help you with your stock trading and investing. The ASX Group's activities span primary and secondary market services, including capital formation and hedging, trading and price discovery (Australian Securities Exchange) central counter party risk transfer (ASX Clearing Corporation); and securities settlement for both the equities and fixed income markets (ASX Settlement Corporation). Target our investor community with our suite of Hotcopper Advertising opportunities. 34.0¢ It has a Good Manufacturing Process (GMP) facility in place for quality control and also holds an ISO certification for the manufacture of its products such as CelGro.